TH1501004430A - Anti-IL-17A antibody and their use in treating disorders Causes of autoimmune diseases and inflammation - Google Patents

Anti-IL-17A antibody and their use in treating disorders Causes of autoimmune diseases and inflammation

Info

Publication number
TH1501004430A
TH1501004430A TH1501004430A TH1501004430A TH1501004430A TH 1501004430 A TH1501004430 A TH 1501004430A TH 1501004430 A TH1501004430 A TH 1501004430A TH 1501004430 A TH1501004430 A TH 1501004430A TH 1501004430 A TH1501004430 A TH 1501004430A
Authority
TH
Thailand
Prior art keywords
inflammation
antibody
autoimmune diseases
treating disorders
disorders causes
Prior art date
Application number
TH1501004430A
Other languages
Thai (th)
Other versions
TH166525A (en
TH166525B (en
Inventor
ปาโดว่า ฟรังโก้ อีฮูเบอร์ โธมัสรอนดัว จีน ไมเคิล เรเน่ ดิ
Original Assignee
โนวาร์ทิส เอจี
Filing date
Publication date
Application filed by โนวาร์ทิส เอจี filed Critical โนวาร์ทิส เอจี
Publication of TH166525A publication Critical patent/TH166525A/en
Publication of TH166525B publication Critical patent/TH166525B/en
Publication of TH1501004430A publication Critical patent/TH1501004430A/en

Links

TH1501004430A 2014-02-07 Anti-IL-17A antibody and their use in treating disorders Causes of autoimmune diseases and inflammation TH1501004430A (en)

Publications (3)

Publication Number Publication Date
TH166525A TH166525A (en) 2017-08-24
TH166525B TH166525B (en) 2017-08-24
TH1501004430A true TH1501004430A (en) 2017-08-24

Family

ID=

Similar Documents

Publication Publication Date Title
HK1250990A1 (en) Factor xi antibodies and methods of use
DK2953969T3 (en) Anti-IL-17A antibodies and their use in the treatment of autoimmune and inflammatory disorders
HUE045754T2 (en) Blautia stercosis and wexlerae for use in treating inflammatory and autoimmune diseases
DK3653221T3 (en) ANTI-PVRIG ANTIBODIES AND METHODS OF USE
KR20180084817A (en) Anti-SIGLEC-9 antibodies and methods of using the same
HK1256088A1 (en) Anti-tfr antibodies and their use in treating proliferative and inflammatory disorders
IL251128A0 (en) Bispecific antibodies and methods of use in ophthalmology
KR102068915B9 (en) Tissue factor pathway inhibitor antibodies and uses thereof
IL249098A0 (en) Methods and compositions for treating allergy and inflammatory diseases
IL267538A (en) Factor xi antibodies and methods of use
BR112016024803A2 (en) abrasive supports and methods of their formation
DK3149049T3 (en) IL-22 FOR USE IN THE TREATMENT OF METABOLISM DISEASES
DK3229827T3 (en) MODIFIED PEPTIDES AND ITS APPLICATION FOR THE TREATMENT OF CHRONIC INFLAMMATORY DISEASES
GB2537783B (en) Compositions used in treating inflammatory and autoimmune diseases
BR112016028653A2 (en) methods of treating neurodevelopmental diseases and disorders
TH1501004430A (en) Anti-IL-17A antibody and their use in treating disorders Causes of autoimmune diseases and inflammation
PL3262069T3 (en) Use of antibodies and antagonists directed against lrg1 in treatment
EP3385282C0 (en) Monoclonal antibodies against bambi and use for the treatment of inflammatory diseases
TH1501007684A (en) Lectin-like oxidized LDL receptor 1 antibodies and their methods of use
TH1501006571A (en) Modified antibodies binding to human FCRN and methods of use